Skip to main content
. 2018 Nov 20;17(2):253–264. doi: 10.5217/ir.2018.00062

Table 4.

Distribution of Participants for Each Advanced Colorectal Neoplasm Risk Score

Risk score APCS score
KCS score
YCS score
Total ACRN Total ACRN Total ACRN
Derivation cohort
 0 9,151 71 (0.8) 7,935 58 (0.7) 2,088 14 (0.7)
 1 21,840 188 (0.9) 15,092 100 (0.7) 6,344 20 (0.3)
 2 9,629 122 (1.3) 14,120 183 (1.3) 6,776 38 (0.6)
 3 772 6 (0.8) 4,413 50 (1.1) 5,794 54 (0.9)
 4 310 6 (1.9) 142 2 (1.4) 7,049 50 (0.7)
 5 6,710 90 (1.3)
 6 3,609 55 (1.5)
 7 2,108 50 (2.4)
 8 1,094 18 (1.6)
 9 128 4 (3.1)
 10 2 0
Validation cohort
 0 3,943 26 (0.7) 3,406 22 (0.6) 931 4 (0.4)
 1 9,360 72 (0.8) 6,476 37 (0.6) 2,745 8 (0.3)
 2 4,080 57 (1.4) 6,111 80 (1.3) 2,984 16 (0.5)
 3 372 8 (2.2) 1,825 27 (1.5) 2,428 23 (0.9)
 4 118 6 (5.1) 55 3 (5.5) 3,011 22 (0.7)
 5 2,804 39 (1.4)
 6 1,508 25 (1.7)
 7 933 14 (1.5)
 8 456 16 (3.5)
 9 71 2 (2.8)
 10 2 0

Values are presented as number (%).

APCS, Asia-Pacific Colorectal Screening; KCS, Korean Colorectal Screening; YCS, Young adult Colorectal Screening; ACRN, advanced colorectal neoplasm.